| Basics |
|
NORTHWEST BIOTHERAPEUTICS INC |
| IPO Date: |
January 1, 2002 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.11 | 3.85%
|
| Avg Daily Range (30 D): |
$0.01 | 4.17%
|
| Avg Daily Range (90 D): |
$0.01 | 5.61%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.82M |
| Avg Daily Volume (30 D): |
2.58M |
| Avg Daily Volume (90 D): |
2.81M |
| Trade Size |
| Avg Trade Size (Sh.): |
932 |
| Avg Trade Size (Sh.) (30 D): |
3,694 |
| Avg Trade Size (Sh.) (90 D): |
4,367 |
| Institutional Trades |
| Total Inst.Trades: |
49 |
| Avg Inst. Trade: |
$1.47M |
| Avg Inst. Trade (30 D): |
$.55M |
| Avg Inst. Trade (90 D): |
$.55M |
| Avg Inst. Trade Volume: |
.33M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.47M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
617.26K |
|
|
| Financials |
| |
TTM |
Q1 2024 |
Q4 2016 |
|
Basic EPS
|
$-.02
|
$-.02
|
|
|
Diluted EPS
|
$-.02
|
$-.02
|
|
|
Revenue
|
$ .23M
|
$ .28M
|
$ .07M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -28.2M
|
$ -18.3M
|
$ -30.71M
|
|
Operating Income / Loss
|
$ -18.5M
|
$ -15.74M
|
$ -21.25M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -4.32M
|
$ -.56M
|
$ 4.83M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Sep 26, 2012:
1:16
|
|
Jun 28, 2007:
1:15
|
|
|
|
